HIV-1 suppression and rare dolutegravir resistance in antiretroviral-experienced people with HIV in Liberia.

Saved in:
Bibliographic Details
Title: HIV-1 suppression and rare dolutegravir resistance in antiretroviral-experienced people with HIV in Liberia.
Authors: Moses JS; Partnership for Research on Vaccines & Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia. SMoses@prevailcr.org.; University of California San Francisco, San Francisco, CA, USA. SMoses@prevailcr.org., Pau AK; National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Kuriakose S; Clinical Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Grandits G; Division of Biostatistics, School of Public health, University of Minnesota, Minneapolis, MN, USA., Reilly C; Division of Biostatistics, School of Public health, University of Minnesota, Minneapolis, MN, USA., Sherman BT; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Chang W; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Dai L; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Khan MA; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Highbarger H; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Mannah M; Partnership for Research on Vaccines & Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia., McCullough J; Advanced BioMedical Laboratories, LLC, Cinnaminson, NJ, USA., Chorley C; Clinical Monitoring Research Program Directorate (CMRPD), Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Morlu I; Partnership for Research on Vaccines & Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia., Dorbor J; Partnership for Research on Vaccines & Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia., Bongolee OT; Partnership for Research on Vaccines & Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia., Slewion R; Partnership for Research on Vaccines & Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia., Akpa E; Clinical Monitoring Research Program Directorate (CMRPD), Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Wilson B; Partnership for Research on Vaccines & Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia., Poole AL; National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Kopka SL; Clinical Monitoring Research Program Directorate (CMRPD), Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Miller T; Clinical Monitoring Research Program Directorate (CMRPD), Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Nuta CJ; John F. Kennedy Medical Center, Monrovia, Liberia., Lindan C; University of California San Francisco, San Francisco, CA, USA., Glidden D; University of California San Francisco, San Francisco, CA, USA., Martin JN; University of California San Francisco, San Francisco, CA, USA., Johnson KL; Partnership for Research on Vaccines & Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia., Dewar RL; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Wachekwa I; Partnership for Research on Vaccines & Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia.; John F. Kennedy Medical Center, Monrovia, Liberia., Migueles SA; National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.; Axle Informatics, North Bethesda, MD, USA.
Source: Communications medicine [Commun Med (Lond)] 2025 May 09; Vol. 5 (1), pp. 164. Date of Electronic Publication: 2025 May 09.
Publication Type: Journal Article
Journal Info: Publisher: Nature Portfolio Country of Publication: England NLM ID: 9918250414506676 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-664X (Electronic) Linking ISSN: 2730664X NLM ISO Abbreviation: Commun Med (Lond) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2730-664X
DOI:10.1038/s43856-025-00875-x